Business
Biocon Limited Press Release Jul 03 2025
Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled "Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars".
About this update from Biocon Limited
[{"type":"text","content":" Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled \"Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars\". View Attachment","length":340,"tagName":"div"}]